Patient Growth Continues

2019 was a fantastic year of patient growth for Althea and on the back of the unrelenting efforts from our sales team, we successfully surpassed our target of 4,000 patients for the year, ending with a total of 4,018 patients being prescribed Althea medicinal cannabis products.

Althea’s strong patient growth continues in 2020 and in February we surpassed 5,000 patients in Australia! This is yet another exciting milestone for the company and is something our hard-working team is very proud of. Thank you to all our fantastic partners and we look forward to servicing even more patients in 2020.